scholarly journals Expression of embryonal stem cell transcription factors in breast cancer: Oct4 as an indicator for poor clinical outcome and tamoxifen resistance

Oncotarget ◽  
2017 ◽  
Vol 8 (22) ◽  
pp. 36305-36318 ◽  
Author(s):  
Jae Moon Gwak ◽  
Milim Kim ◽  
Hyun Jeong Kim ◽  
Min Hye Jang ◽  
So Yeon Park
Keyword(s):  
Breast Cancer ◽  
Stem Cell ◽  
Transcription Factors ◽  
Clinical Outcome ◽  
Tamoxifen Resistance ◽  
Poor Clinical Outcome ◽  
Embryonal Stem Cell ◽  
Embryonal Stem

The elevated preoperative derived neutrophil-to-lymphocyte ratio predicts poor clinical outcome in breast cancer patients

Tumor Biology ◽  
2015 ◽  
Vol 37 (1) ◽  
pp. 361-368 ◽  
Author(s):  
Sabine Krenn-Pilko ◽  
Uwe Langsenlehner ◽  
Tatjana Stojakovic ◽  
Martin Pichler ◽  
Armin Gerger ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Clinical Outcome ◽  
Cancer Patients ◽  
Neutrophil To Lymphocyte Ratio ◽  
Breast Cancer Patients ◽  
Poor Clinical Outcome ◽  
Lymphocyte Ratio

Abstract 4640: High expression of the stem cell marker LGR5 is associated with a poor clinical outcome in patients with Ewing's sarcoma

2010 ◽  
Author(s):  
Christopher A. Scannell ◽  
Diana Abdueva ◽  
Lingyun Ji ◽  
Cornelia von Levetzow ◽  
Richard Sposto ◽  
...  
Keyword(s):  
Stem Cell ◽  
Clinical Outcome ◽  
Ewing’S Sarcoma ◽  
Ewing's Sarcoma ◽  
High Expression ◽  
Stem Cell Marker ◽  
Cell Marker ◽  
Poor Clinical Outcome
Sign in / Sign up

Export Citation Format

Share Document